TLCR Reading Tools
How to cite item
Nivolumab as first-line treatment in non-small cell lung cancer patients—key factors: tumor mutation burden and PD-L1 ≥50%
Citation Format
ABNT
APA
BibTeX
CBE
EndNote - EndNote format (Macintosh & Windows)
MLA
ProCite - RIS format (Macintosh & Windows)
RefWorks
Reference Manager - RIS format (Windows only)
Turabian
@article{{TLCR}{18439}, author = {Zarogoulidis, P., Papadopoulos, V., Maragouli, E., Papatsibas, G., Sardeli, C., Man, Y., Bai, C., Huang, H.}, title = {Nivolumab as first-line treatment in non-small cell lung cancer patients—key factors: tumor mutation burden and PD-L1 ≥50%}, journal = {Translational Lung Cancer Research}, volume = {7}, number = {Suppl 1}, year = {2018}, url = {https://tlcr.amegroups.org/article/view/18439} }